Aileron Therapeutics (ALRN) Names Jeffrey A. Bailey to Board

March 19, 2018 7:03 AM EDT Send to a Friend
Aileron Therapeutics (NASDAQ: ALRN) today announced the appointment of Jeffrey A. Bailey as Chairman of its Board of Directors. Mr ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login